Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06491537

Time-restricted Eating for Postpartum Weight Loss

This study is being done to assess the feasibility and acceptability of a time-restricted eating intervention among postpartum women with overweight/obesity.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

Location status: Recruiting

Location contact

Camille S Worthington, PhD

CONTACT

[email protected]

205-975-7274

About this study

Existing postpartum weight retention (PPWR) interventions have had limited success. Timing-based interventions, such as early time-restricted eating (eTRE), show significant improvements in cardiometabolic endpoints in non-postpartum cohorts. The purpose of the Time4Mom study is to conduct a pilot randomized trial of a postpartum-adapted eTRE intervention to test feasibility and acceptability of the eTRE intervention and trial protocol. We will also compare changes in clinical outcomes of interest and patient-reported outcomes between eTRE (intervention) and control groups.

This 2-arm trial will randomize 60 postpartum women to either Control or eTRE for 12 weeks (n=30/group).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older
  • Experienced a healthy singleton pregnancy
  • 6-16 weeks postpartum at enrollment
  • Body mass index ≥25 at enrollment
  • Willing to consent

Exclusion criteria

  • Self-reported major health condition (such as renal disease, cancer, or Type 1 or Type 2 diabetes)
  • Current treatment for severe psychiatric disorder (such as schizophrenia)
  • Self-reported diagnosis of anorexia or bulimia
  • Current use of medication expected to significantly impact body weight
  • Current substance abuse
  • Participation in another dietary and/or weight management intervention postpartum
  • Performing overnight shiftwork >1x/week
  • Regularly fasting ≥14 hr/day or completing twelve or more 24-hr fasts within the past year
  • Unable to understand and communicate in English

Treatment and study plan

Early Time-Restricted Eating (eTRE)

Behavioral

12 weeks of eTRE intervention. Study staff will provide 7 support sessions with brief behavioral support, including evidence based strategies of problem-solving, action planning, and motivational interviewing.

Other names: Intermittent Fasting, Timed Eating

Control

Behavioral

The control group will be instructed to maintain their average eating window for the 12-week period. Study staff will contact participants 7 times to encourage maintenance.

Primary outcomes

  1. Study Participation Rate

    Time frame: Baseline (6-16 weeks postpartum)

    Percentage of eligible subjects who agreed to participate out of those who were screened.

  2. Oral Glucose Tolerance Test (OGTT)

    Time frame: Baseline (6-16 weeks postpartum), follow-up (18-28 weeks postpartum)

    Indices of glucose tolerance and insulin action will be assessed via a 2-hr OGTT. Participants will consume a 75-g glucose load within 5 minutes, which will be timed to begin at each participant's habitual breakfast time. Fasting blood samples will be collected at 15-, 30-, 60-, 90-, and 120-minutes relative to glucose consumption.

  3. Energy Intake

    Time frame: Baseline (6-16 weeks postpartum), follow-up (18-28 weeks postpartum)

    Dietary intake will be collected at each assessment by 3 self-administered 24-hr recalls on 3 non-consecutive days (2 weekdays, 1 weekend day) using the Automatic Self-Administered 24-hour Dietary Assessment Tool (ASA24), an online platform developed and hosted by the National Cancer Institute. Total energy intake and kcals from each macronutrient will be derived from 24-hr recalls.

  4. Participant Retention

    Time frame: Baseline (6-16 weeks postpartum), follow-up (18-28 weeks postpartum)

    The proportion of enrolled participants who complete follow-up.

  5. Change in Visceral Fat

    Time frame: Baseline (6-16 weeks postpartum), follow-up (18-28 weeks postpartum)

    Bioelectrical impedance analysis (BIA) (seca® mBCA 514) will be used to assess visceral adipose tissue.

  6. Participant Adherence to Intervention

    Time frame: Collected daily from intervention start (6-16 weeks postpartum) to follow-up (18-28 weeks postpartum)

    Adherence to eating window based on responses to daily electronic REDCap surveys that record start and stop time of the eating window.

  7. eTRE Intervention Satisfaction

    Time frame: Baseline (6-16 weeks postpartum), follow-up (18-28 weeks postpartum)

    Participant satisfaction with the eating schedule will be assessed using a 5-point Likert scale. Long-term eating schedule preferences will be assessed by asking intervention participants at follow-up whether they plan to: (a) continue following the assigned eTRE schedule; (b) follow a modified eTRE schedule [and specifying what modifications they plan to make]; or (c) stop eTRE and return to prior meal timing habits.

    Qualitative data on eTRE intervention satisfaction will be collected at follow-up. These one-on-one interviews will be conducted in-person or remotely via videoconferencing. Topics explored will include participants' typical day during the intervention, experiences with eTRE, adherence barriers/facilitators, intervention satisfaction, and suggested improvements.

  8. Change in Body Weight

    Time frame: Baseline (6-16 weeks postpartum), follow-up (18-28 weeks postpartum)

    Body weight measured at baseline and follow-up will be used to calculate weight change.

  9. Change in Subjective Appetite

    Time frame: Baseline (6-16 weeks postpartum), follow-up (18-28 weeks postpartum)

    Subjective ratings of appetite (hunger and satiety) over the past week will be collected at baseline and follow-up using visual analogue scales scored from 0 (less hunger/less satiety) to 100 (more feelings of hunger/more feelings of satiety) based on the response along a 100-mm line.

  10. Self-Reported Fatigue

    Time frame: Baseline (6-16 weeks postpartum), follow-up (18-28 weeks postpartum)

    Fatigue will be assessed using the NIH's validated 8-item Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Short Form (SF) 8a to assess fatigue over the past 7 days. The PROMIS Fatigue SF 8a is scored on a T-score metric with a mean of 50 and standard deviation of 10. The T-score metric is referenced to the US general population with respect to race/ethnicity, age, education, and sex (e.g., T-score of 40 would be one SD below the US general population). A higher PROMIS T-score represents more of the concept being measured (higher score indicates more fatigue).

Study contacts

Contact information is provided by the study sponsor or research team.

Camille S Worthington, PhD

CONTACT

[email protected]

205.975.7274

Sponsors and collaborators

Lead sponsor

University of Alabama at Birmingham

Other

Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Registry information

Official study title

Use of Early Time-restricted Eating to Promote Weight Loss and Improve Cardiometabolic Health in Postpartum Women

Acronym: Time4Mom

Important dates

Study start
2025
Primary completion
2029
Study completion
2029
First posted
Jul 9, 2024
Registry last updated
Jun 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.